|
October 22, 2021
Contact: Jonathan Modie, 971-246-9139, PHD.Communications@dhsoha.state.or.us
What: The Northwest Regional Newborn Bloodspot Screening (NWRNBS) Advisory Board is holding a public meeting. The meeting is accessible by a webinar link or conference line.
Agenda: Welcome, introductions, housekeeping; information from the Department of Justice and Oregon Health Authority Government Relations on board processes; community birth provider Medicaid reimbursement; public comment; statute review; wrap-up and next steps.
When: Monday, Nov. 1, 9 a.m.-1 p.m. A 15-minute public comment period is scheduled at about 11:30 a.m.; comments are limited to one to three minutes depending on the number of people providing comments.
Where: Remote access only. Zoom access: https://pdx.zoom.us/j/88965026032
Dial by your location: +1 971 247 1195 US (Portland)
+1 720 928 9299 US (Denver)
+1 253 215 8782 US (Tacoma)
+1 602 753 0140 US (Phoenix)
Meeting ID: 889 6502 6032
Background: The Northwest Regional Newborn Bloodspot Screening (NWRNBS) Program screens newborns for endocrine, hemoglobin, cystic fibrosis, immunodeficiency and metabolic disorders that may not be clinically evident in the first few days or weeks of life. Detecting these conditions early allows the infant to be referred for diagnosis and appropriate treatment to prevent death or disability. For more information, visit www.healthoregon.org/nbs.
###
Everyone has a right to know about and use Oregon Health Authority (OHA) programs and services. OHA provides free help. Some examples of the free help OHA can provide are:
- Sign language and spoken language interpreters
- Written materials in other languages
- Braille
- Large print
- Audio and other formats
If you need help or have questions, please contact Nicole Galloway at 503-693-4172, 711 TTY or NBS.AdvisoryBoard@dhsoha.state.or.us at least 48 hours before the meeting.
###
 You are subscribed to Oregon Health Authority News Releases. View all OHA news releases.
|
